Resveratrol and Diabetic Retinopathy

Could a multi-target molecule be used for earlier intervention of DR?

1

Current diabetic retinopathy therapies are reactive and do not address early neuroinflammatory and metabolic disturbances.
2

Resveratrol is identified as a multi-target modulator that influences mitochondrial health and inflammatory signaling in early diabetic retinopathy.
3

Resveratrol protects mitochondria by activating SIRT1-dependent pathways, improving dynamics and reducing oxidative stress.
4

The compound also suppresses multiple inflammatory mediators and shifts microglial behavior towards a reparative state.
5

While promising, resveratrol is not yet ready for clinical use due to unresolved issues like bioavailability and optimal dosing.

1